Common Contracts

EX-2.1 2 dex21.htm ASSET PURCHASE AGREEMENT EXECUTION COPY ASSET PURCHASE AGREEMENT dated as of September 23, 2009 among LEO PHARMA A/S, LEO LABORATORIES LTD., WARNER CHILCOTT PLC, WARNER CHILCOTT COMPANY, LLC and WARNER CHILCOTT (US), LLC PAGE...

Asset Purchase Agreement • May 5th, 2020 • New York

• Contract Type
  Asset Purchase Agreement
• Filed
  May 5th, 2020
• Jurisdiction
  New York

* Schedules have been omitted pursuant to Item 601(b)(2) of Regulation S-K. Warner Chilcott agrees to furnish supplementally to the Securities and Exchange Commission a copy of any omitted schedule upon request.

ASSET PURCHASE AGREEMENT dated as of September 23, 2009 among LEO PHARMA A/S, LEO LABORATORIES LTD., WARNER CHILCOTT PLC, WARNER CHILCOTT COMPANY, LLC and WARNER CHILCOTT (US), LLC

Asset Purchase Agreement • September 23rd, 2009 • Warner Chilcott PLC • Pharmaceutical preparations • New York

• Contract Type
  Asset Purchase Agreement
• Filed
  September 23rd, 2009
• Company
  Warner Chilcott PLC
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

ASSET PURCHASE AGREEMENT (this “Agreement”) dated as of September 23, 2009, among LEO PHARMA A/S, an Aktieselskab organized under the laws of Denmark (“Buyer Parent”), LEO LABORATORIES LTD., a limited liability company formed under the laws of Ireland (“Irish Buyer”; and, together with Buyer Parent, the “Buyers”), WARNER CHILCOTT PLC, an Irish public limited company (“Seller Parent”), WARNER CHILCOTT COMPANY, LLC, a Puerto Rican limited liability company and an indirect wholly-owned subsidiary of Seller Parent (“WCCL”), and WARNER CHILCOTT (US), LLC, a Delaware limited liability company and an indirect wholly-owned subsidiary of Seller Parent (“WC US”; and, together with Seller Parent and WCCL, each a “Seller” and collectively the “Sellers”).